000			01454 a2200433 4500
005			20250514060551.0
264		0	_c20030411
008			200304s 0 0 eng d
022			_a0017-5749
024	7		_a10.1136/gut.52.3.377 _2doi
040			_aNLM _beng _cNLM
100	1		_aStallmach, A
245	0	0	_aSafety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease. _h[electronic resource]
260			_bGut _cMar 2003
300			_a377-82 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Disease
650	0	4	_aAdult
650	0	4	_aAnti-Inflammatory Agents _xtherapeutic use
650	0	4	_aCrohn Disease _xdrug therapy
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDrug Resistance
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInflammatory Bowel Diseases _xdrug therapy
650	0	4	_aInfusions, Intravenous
650	0	4	_aMale
650	0	4	_aPilot Projects
650	0	4	_aPrednisolone _xtherapeutic use
650	0	4	_aProspective Studies
700	1		_aWittig, B M
700	1		_aMoser, C
700	1		_aFischinger, J
700	1		_aDuchmann, R
700	1		_aZeitz, M
773	0		_tGut _gvol. 52 _gno. 3 _gp. 377-82
856	4	0	_uhttps://doi.org/10.1136/gut.52.3.377 _zAvailable from publisher's website
999			_c12381659 _d12381659